A faster path to lasting relief from depression.

SAINT® is the first and only FDA-cleared therapy to achieve remission in just five days.

Overlay Image

I’m seeking treatment

Overlay Image

I’m a healthcare professional

HOW SAINT WORKS

Treating depression in days, not weeks.

SAINT is an advanced, targeted form of TMS therapy that uses precision neuromodulation to deliver rapid and lasting remission from Major Depressive Disorder (MDD) in an accelerated, 5-day treatment.

Find a provider

Meet with a Verified SAINT Provider to determine if SAINT is the right treatment for you.

The fMRI scan creates a unique map of your brain’s neural circuitry in about 45 minutes, allowing SAINT to target your depression precisely.

Our targeting algorithm uses the brain scan to map out the perfect location to deliver effective stimulation and treat your depression more precisely.

SAINT TMS treatment takes just five days. Each day consists of ten 10-minute sessions per day, with 50-minute breaks in between. Most people begin to feel a change in their mood within just a couple of days.

THE FACTS

SAINT helps people get better, faster.

Unlike conventional treatments that can take weeks or months to start working, SAINT can bring remission from depression symptoms in days.

0

days of noninvasive, non-drug treatment (versus 6-9 weeks for standard TMS).

0 %

of trial participants entered remission from their depression.

0

days to remission on average instead of weeks or months.

0

clinic visits (versus 30-36 for standard TMS).

0

days of noninvasive, non-drug treatment (versus 6-9 weeks for standard TMS).

0 %

of trial participants entered remission from their depression.

0

days to remission on average instead of weeks or months.

0

clinic visits (versus 30-36 for standard TMS).

Cole EJ, Stimpson KH, Bentzley BS, et al.: Stanford Accelerated Intelligent Neuromodulation Therapy for treatment-resistant depression. Am J Psychiatry 2020; 177:716–726 2.Cole EJ, Phillips AL, Bentzley, BS, et al.: Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial. Am J Psychiatry 2021; 179:2, 132–141.

Built with purpose, backed by science.

We weren’t satisfied with the limits of traditional mental health care, so we set out to create a rapid-acting therapy grounded in innovation and personalization.

FDA cleared

SAINT received Breakthrough Device Designation, recognizing its potential to make life-changing treatment and remission more accessible to patients.

Developed at Stanford

SAINT was developed by psychiatrists and neuroscientists at Stanford’s Brain Stimulation Lab, driven by a mission to reimagine psychiatry and transform how brain conditions are treated.

Find SAINT® near you

Feeling better starts with finding the right care. Find a Verified SAINT Provider near you.